PD-1 is expressed on T-cells, and PD-L1 is expressed on antigen-presenting cells; similarly, blocking the binding of PD-1 and PD-L1 leads to enhanced T-cell response against cancer cells [6,7]. This evidence concerns the gene CD274 and cancer.